Wird geladen...
Current Strategies for the Manufacture of Small Size Tissue Engineering Vascular Grafts
Occlusive arterial disease, including coronary heart disease (CHD) and peripheral arterial disease (PAD), is the main cause of death, with an annual mortality incidence predicted to rise to 23.3 million worldwide by 2030. Current revascularization techniques consist of angioplasty, placement of a st...
Gespeichert in:
| Veröffentlicht in: | Front Bioeng Biotechnol |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Frontiers Media S.A.
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5916236/ https://ncbi.nlm.nih.gov/pubmed/29721495 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fbioe.2018.00041 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|